UNSPSC 51392202: Apraclonidine or iopidine

This classification denotes an alpha-adrenergic agonist with the molecular formula C9H10Cl2N4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 843CEN85DI, chemically known as 2,6-dichloro-n-(4,5-dihydro-1h-imidazol-2-yl)benzene-1,4-diamine but generally known as apraclonidine, which bears US NIH Compound Identifier 2216. Apraclonidine most often comes in base and hydrochloride forms. European Medicines Agency schedules Apraclonidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05539MIG.

UNSPSC 51392202 Apraclonidine or iopidine is a Commodity code that represents pharmaceutical products used in ophthalmic and emergency medical contexts, but the recent state and local solicitation activity under this code shows a substantial mismatch with the nominal scope. Seminole County, Florida posted an IFB (IFB60459723LAS) in June 2026 seeking naloxone and drug deactivation systems — neither of which aligns with apraclonidine or iopidine, which are pharmaceutical agents used in eye care and glaucoma treatment. The county's procurement does not reflect the code's stated pharmaceutical category; instead, it targets emergency overdose response and harm-reduction products for community health delivery. This mismatch suggests the code carries limited relevant recent activity for business development professionals focused on ophthalmic or eye-care pharmaceutical supply.

The Seminole County opportunity remains the only recent state or local solicitation appearing under this code. The IFB required 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a response deadline of July 26, 2023. Vendors must include all shipping and delivery costs, comply with drug-free workplace certification and E-Verify requirements, maintain workers' compensation and commercial general liability insurance, and commit to an initial two-year term with an optional one-year renewal. The procurement did not specify set-aside designations and was potentially funded through FEMA, introducing federal compliance obligations including adherence to the Clean Air Act and Federal Water Pollution Control Act. Geographic and issuing-body data from the source do not support broader characterization beyond this single Seminole County transaction.